caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1831181452

Rafael Betancourt GarciaMD

Hematology-OncologyGuaynabo, PRI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Rafael Betancourt Garcia's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HOSPITAL ESPANOL AUXILIO MUTUO DE PUERTO RICO, INC.57330
RENDON, WILFREDO1928
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
93
By payment type
Food and Beverage$2K
Education$13
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,261
Beneficiaries
—
Total drug cost
$3.7M
Distinct drugs
27
Brand share
24.3%
Top prescribed drugs
Anastrozole186 claims
Pantoprazole Sodium167 claims
Ondansetron Hcl137 claims
Prochlorperazine Maleate121 claims
Lenalidomide116 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
79
Unique beneficiaries
—
Total services
728
Distinct HCPCS
4
Medicare payment
$24K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 71 Hematology-Oncology providers in PR — top quintile (cohort median 980).